Vista Investment Partners II’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$598K Buy
2,375
+41
+2% +$8.82K 0.23% 91
2026
Q1
$508K Sell
2,334
-415
-15% -$92.1K 0.23% 89
2025
Q4
$628K Buy
2,749
+317
+13% +$72.2K 0.27% 83
2025
Q3
$563K Sell
2,432
-12
-0.5% -$2.44K 0.26% 80
2025
Q2
$454K Sell
2,444
-114
-4% -$21.2K 0.22% 86
2025
Q1
$536K Buy
2,558
+224
+10% +$43.5K 0.3% 75
2024
Q4
$415K Buy
+2,334
New +$429K 0.24% 83

Other funds holding ABBV

Vista Investment Partners II's ABBV Position: Q2 2026 in Review

Vista Investment Partners II increased its AbbVie (ABBV) stake by 1.8% in Q2 2026, buying an estimated $8.82K and bringing the position to 2,375 shares worth $598K. The position accounts for 0.23% of the portfolio, ranked #91.

Vista Investment Partners II first reported a position in ABBV in Q4 2024 and has held it in 7 quarters since. The position peaked at $628K in Q4 2025. 2,121 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Vista Investment Partners II held 2,375 shares of AbbVie worth $598K as of Q2 2026.
  • Vista Investment Partners II bought 41 AbbVie shares in Q2 2026, an estimated $8.82K.
  • AbbVie made up 0.23% of Vista Investment Partners II's portfolio in Q2 2026, its #91 holding.
  • Vista Investment Partners II first reported a position in AbbVie in Q4 2024 and has held it in 7 quarters since.
  • Vista Investment Partners II's AbbVie position peaked at $628K in Q4 2025.
  • 2,121 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Vista Investment Partners II's 13F filing for Q2 2026, filed 21 Jul 2026.